New research from the Momentum Health Study, a program supported by the BC Centre for Excellence in HIV/AIDS, finds rates of smoking are three times higher among gay and bisexual men compared to the general population in a province that has the lowest rates of smoking in the country.
Most people infected with Hep C do not experience any symptoms for decades. For those that do, the symptoms are often mild and flu-like, for example, feeing very tired, sore muscles, fever and nausea. These symptoms usually occur within 2 weeks to 6 months of exposure.
The International AIDS Conference is the premier gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic. It is a chance to assess where we are, evaluate recent scientific developments and lessons learnt, and collectively chart a course forward.
The BC Centre for Excellence (BC-CfE) is excited to launch an art contest to mark World Hepatitis Day on July 28th 2017. With this contest we hope to raise awareness about hepatitis C virus (HCV).
In Canada, it is estimated that 300,000 people are living with HCV with approximately 80,000 of those living in BC. HCV is passed on when the blood from someone who has HCV gets into the bloodstream of another person. This can happen with high risk sexual practices; sharing injection equipment or getting a tattoo or piercing with unsterilized equipment.
Participants, within a BC-CfE study cohort of gay, bisexual and other men who have sex with men, describe having to advocate for themselves and educate health care providers on their sexual health needs.
Congratulations to Dr. Julio Montaner, who was recently honoured by Dr. Juan A. Tobias, Rector of the Universidad del Salvador, in Buenos Aires, Argentina, by Dr. Daniel MartÃnez, Dean of Medicine, and by Dra. Claudia RamÃrez, Academic Secretary, with a doctor honoris causa (honorary doctorate degree) from the University’s Faculty of Medicine.
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
